Thanks to modern technology and medical breakthrough, a metro Detroit boy with cerebral palsy is experiencing a miracle.
Gary Dunbar, director of the neuroscience program at Central Michigan University, believes his research team may have taken a step in the right direction toward promotING the recovery of the brain after damage caused by stroke, traumatic brain injury, and neurodegenerative diseases such as Parkinson’s, Huntington’s and Alzheimer’s.
Two University of Michigan clinician-scientists will receive three-year grants to pursue translational medical research aimed at helping patients with life-altering neurological disorders, the A. Alfred Taubman Medical Research Institute announced.
It’s a ground breaking new FDA trial. And a Metro Detroit boy is one of the first children in the world to participate in the procedure to treat his cerebral palsy with the use of cord blood stem cells.
The latest event and meeting notices from Michigan’s technology-focused companies, institutions and groups
Researchers from South Korea, Sweden, and the United States have collaborated on a project to restore neuron function to parts of the brain damaged by Huntington’s disease by successfully transplanting HD-induced pluripotent stem cells into animal models.
Findings from a multi-center trial led by researchers at Beaumont Hospital in Royal Oak may give urologists another minimally invasive treatment option for women with stress urinary incontinence.
The first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig’s disease, opening the door for further research on this innovative approach.
Stem cells could help an old dog learn new tricks.
Drugs that could bring health to tens of thousands of kidney patients, cure osteoporosis and advance the battle against cancer were featured Wednesday on the second day of MichBio Expo, the annual meeting of the state’s biosciences business community.